新型冠狀病毒

Beijing’s failure to import mRNA Covid jabs ‘mind-boggling’, says BeiGene

Chinese biotech’s research chief calls decision ‘unfortunate’ as zero-Covid policy strangles economy

One of China’s most prominent biotech companies said it was “mind-boggling” that Beijing has not allowed sales of Covid-19 vaccines using technology pioneered by Moderna and BioNTech/Pfizer.

BeiGene’s research chief told the Financial Times it was “unfortunate” that Chinese authorities had not approved messenger RNA shots, which provide longer lasting and higher levels of protection than vaccines made by homegrown rivals.

China is the only big economy that has maintained strict quarantine for international arrivals and lockdowns to curb outbreaks of the virus. The pandemic policies have stunted the country’s economic growth and disrupted global supply chains.

您已閱讀16%(665字),剩餘84%(3620字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×